• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Indian J Public Health Impact of Nonpharmacological Interventions on COVID-19 Transmission Dynamics in India

tetano

Editor, Senior Moderator
Indian J Public Health


. 2020 Jun;64(Supplement):S142-S146.
doi: 10.4103/ijph.IJPH_510_20.
Impact of Nonpharmacological Interventions on COVID-19 Transmission Dynamics in India


Purvi Patel[SUP] 1 [/SUP], Aditya Athotra[SUP] 2 [/SUP], T P Vaisakh[SUP] 1 [/SUP], Tanzin Dikid[SUP] 3 [/SUP], Sudhir Kumar Jain[SUP] 4 [/SUP], NCDC COVID Incident Management Team



Affiliations

Abstract

Background: As of May 4, 2020, India has reported 42,836 confirmed cases and 1,389 deaths from COVID-19. India's multipronged response included nonpharmacological interventions (NPIs) like intensive case-based surveillance, expanding testing capacity, social distancing, health promotion, and progressive travel restrictions leading to a complete halt of international and domestic movements (lockdown).
Objectives: We studied the impact of NPI on transmission dynamics of COVID-19 epidemic in India and estimated the minimum level of herd immunity required to halt it.
Methods: We plotted time distribution, estimated basic (R[SUB]0[/SUB]) and time-dependent effective (R[SUB]t[/SUB]) reproduction numbers using software R, and calculated doubling time, the growth rate for confirmed cases from January 30 to May 4, 2020. Herd immunity was estimated using the latest R[SUB]t[/SUB]value.
Results: Time distribution showed a propagated epidemic with subexponential growth. Average growth rate, 21% in the beginning, reduced to 6% after an extended lockdown (May 3). Based on early transmission dynamics, R[SUB]0[/SUB]was 2.38 (95% confidence interval [CI] =1.79-3.07). Early, unmitigated R[SUB]t[/SUB]= 2.51 (95% CI = 2.05-3.14) (March 15) reduced to 1.28 (95% CI = 1.22-1.32) and was 1.83 (95% CI = 1.71-1.93) at the end of lockdown Phase 1 (April 14) and 2 (May 3), respectively. Similarly, average early doubling time (4.3 days) (standard deviation [SD] = 1.86) increased to 5.4 days (SD = 1.03) and 10.9 days (SD = 2.19). Estimated minimum 621 million recoveries are required to halt COVID-19 spread if R[SUB]t[/SUB]remains below 2.
Conclusion: India's early response, especially stringent lockdown, has slowed COVID-19 epidemic. Increased testing, intensive case-based surveillance and containment efforts, modulated movement restrictions while protecting the vulnerable population, and continuous monitoring of transmission dynamics should be a way forward in the absence of effective treatment, vaccine, and undetermined postinfection immunity.

Keywords: COVID-19; India; reproduction number; severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom